Oracle Unveils New Version of Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service

Wed Feb 6, 2013 8:00am EST

* Reuters is not responsible for the content in this press release.

  REDWOOD SHORES, CA, Feb 06 (Marketwire) -- 
Oracle (NASDAQ: ORCL)

    News Facts


--  Oracle Health Sciences today announced the availability of Oracle
    Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud
    Service 5.0, the latest version of the cloud-based clinical trial
    operations solution that enables life sciences organizations to plan,
    source and track clinical projects and financial performance via a
    single, integrated platform.
--  The newest release now provides support for phase I trials, which when
    combined with existing capabilities, enables organizations to support
    a broad range of clinical trials -- from initial safety screenings to
    complex testing and post-approval studies -- in one scalable and
    flexible solution.
--  Further expanding the breadth and study types that sponsors and
    contract research organizations (CROs) can create and track, the
    latest release also provides support for multiple treatment arm
    studies -- including complex cross over studies, in which different
    types and sequences of treatment courses are administered to various
    study groups.
--  Oracle Health Sciences ClearTrial Plan and Source is now delivered via
    the Oracle Health Sciences Cloud, providing users with improved
    performance, availability and fault tolerance. In addition, as a
    cloud-based solution, users will gain immediate access to ClearTrial's
    enhanced functionality and improved user interface.

    

Supporting Quote


--  "We remain committed to evolving the breadth and depth of Oracle
    ClearTrial Plan and Source Cloud Service's capabilities to provide
    life sciences organizations with the tools they need to conduct and
    track increasingly complex clinical trials across diverse geographies,
    outsourcers, therapeutic areas and trial phases," said Neil de
    Crescenzo, senior vice president and general manager, Oracle Health
    Sciences. "The new capabilities will allow life sciences organizations
    to gain a competitive edge in the marketplace while accelerating the
    process of bringing new therapies to market."

    

Supporting Resources


--  Oracle in Health Sciences
--  Oracle Health Sciences ClearTrial Plan and Source Cloud Service
--  Chorus Pharma Makes Clinical Trial Budgets More Precise, Less Variable
    and Enhances Clinical Trial Value Proposition
--  Follow Oracle Health Sciences on Twitter
--  Join the Oracle Health Sciences Community on Facebook
--  Oracle Health Sciences on YouTube

    

About Oracle 
 Oracle engineers hardware and software to work
together in the cloud and in your data center. For more information about
Oracle (NASDAQ: ORCL), visit www.oracle.com.

    About Oracle in Industries
 Oracle industry solutions leverage the
company's best-in-class portfolio of products to address complex business
processes relevant to health sciences, helping speed time to market,
reduce costs, and gain a competitive edge.

Trademarks
 Oracle and Java
are registered trademarks of Oracle and/or its affiliates. Other names
may be trademarks of their respective owners.

    

Contact Info

Greg Lunsford
Oracle
+1.650.506.6523
greg.lunsford@oracle.com

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
mtobin@okco.com 

Copyright 2013, Marketwire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.